Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT06174779
PHASE3
A Study to Evaluate Efficacy and Safety of HM11260C in Adult Obesity Patients Without Diabetes Mellitus
Sponsor: Hanmi Pharmaceutical Company Limited
View on ClinicalTrials.gov
Summary
A multicenter, randomized, double-blind, phase 3 study to evaluate efficacy and safety of HM11260C in adult obesity patients without diabetes mellitus
Official title: A Multicenter, Randomized, Double-blind, Phase 3 Study to Evaluate Efficacy and Safety of HM11260C in Adult Obesity Patients Without Diabetes Mellitus
Key Details
Gender
All
Age Range
19 Years - Any
Study Type
INTERVENTIONAL
Enrollment
420
Start Date
2024-01-03
Completion Date
2026-07-31
Last Updated
2025-06-06
Healthy Volunteers
No
Conditions
Interventions
DRUG
HM11260C
Test drug
DRUG
Placebo
Placebo drug
Locations (1)
Kangbuk samsung hospital
Seoul, South Korea